SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : The thread of life

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (874)7/12/2006 10:40:56 PM
From: Mike McFarland of 1336
 
(trivia game) ax200 is at LION now
lionbioscience.com

rather convoluted, but it is the Dietmar Hopp family,
not really LION

Initially, the Hopp family (through two of its subsidiaries), Axaron Bioscience AG and BASF AG have acquired all the shares in SYGNIS Bioscience GmbH & Co. KG, which will assume the business activities of Axaron following the approval of Axaron’s shareholders Axaron. Axaron’s annual general meeting will take place in Ludwigshafen on August 10, 2006.
Furthermore, the management and supervisory board of LION resolved on July 5, 2006 to use 78.6 percent of its approved capital to acquire all the shares in SYGNIS Bioscience GmbH & Co. KG. Some 7.8 million new LION shares will be issued to the shareholders of the KG and in exchange LION will receive all the shares in the KG.. The new shareholder structure after the transaction will be as follows: Hopp family 20.5 percent, Friedrich von Bohlen and Halbach (founder and chairman of the supervisory board of LION) 7.6 percent, BASF AG and Bayer AG 5.1 percent each, former shareholders of LION bioscience AG 61.7 percent.
In addition, there are plans to further increase the equity of the company through appropriate corporate measures. This will allow it to further expand its CNS pipeline through targeted product acquisitions and in-house development.

Hopp makes takeover offer to LION shareholders
The transaction process will lead to a change in the corporate direction as well as the opportunity and risk profile of LION. As a result, Dietmar Hopp announced yesterday (July 5) that the subsidiaries of the Hopp family will make a voluntary offer of EUR 1.82 to acquire the shares of all LION shareholders. The offer documents will be submitted in the coming weeks to the German Financial Supervisory Authority (Bundesanstalt für Finanzdienstleitungsaufsicht, BaFin) for examination. LION shareholders therefore have the possibility to decide to continue to invest in the company in the future.


Anyway, I remember thinking at one time that Lynx
had an asset in Axaron, but it went away and now
I see it popping up here...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext